0.3548
price down icon5.89%   -0.0222
after-market アフターアワーズ: .36 0.0052 +1.47%
loading
前日終値:
$0.377
開ける:
$0.377
24時間の取引高:
1.59M
Relative Volume:
2.53
時価総額:
$20.73M
収益:
-
当期純損益:
$-123.46M
株価収益率:
-0.137
EPS:
-2.59
ネットキャッシュフロー:
$-104.11M
1週間 パフォーマンス:
+0.80%
1か月 パフォーマンス:
-12.63%
6か月 パフォーマンス:
-28.98%
1年 パフォーマンス:
-79.13%
1日の値動き範囲:
Value
$0.3499
$0.379
1週間の範囲:
Value
$0.3254
$0.415
52週間の値動き範囲:
Value
$0.2601
$2.525

Bioatla Inc Stock (BCAB) Company Profile

Name
名前
Bioatla Inc
Name
セクター
Healthcare (1164)
Name
電話
858-558-0708
Name
住所
11085 TORREYANA ROAD, SAN DIEGO
Name
職員
61
Name
Twitter
Name
次回の収益日
2025-03-21
Name
最新のSEC提出書
Name
BCAB's Discussions on Twitter

BCAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BCAB
Bioatla Inc
0.3548 22.02M 0 -123.46M -104.11M -2.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Bioatla Inc Stock (BCAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-13 ダウングレード H.C. Wainwright Buy → Neutral
2022-09-15 開始されました JMP Securities Mkt Outperform
2022-05-05 ダウングレード Credit Suisse Outperform → Neutral
2022-03-21 開始されました H.C. Wainwright Buy
2021-10-15 再開されました BTIG Research Buy
2021-06-28 開始されました ROTH Capital Buy
2021-05-05 再開されました Credit Suisse Outperform
2021-04-26 再開されました Credit Suisse Outperform
2021-01-11 開始されました BTIG Research Buy
2021-01-11 開始されました Credit Suisse Outperform
2021-01-11 開始されました JP Morgan Overweight
2021-01-11 開始されました Jefferies Buy
すべてを表示

Bioatla Inc (BCAB) 最新ニュース

pulisher
Jul 25, 2025

BioAtla Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives BioAtla Inc. stock priceTriple-digit return opportunities - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about BioAtla Inc. stockConsistently high returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

Is Now The Time To Buy BioAtla Inc (NASDAQ: BCAB) Stock? - Stocksregister

Jul 22, 2025
pulisher
Jul 22, 2025

Is BioAtla Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is BioAtla Inc. stock a good hedge against inflationFree Consultation - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

What analysts say about BioAtla Inc. stock outlookFast Gains With Reduced Risk - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting - The Manila Times

Jul 17, 2025
pulisher
Jul 15, 2025

What makes BioAtla Inc. stock price move sharplyTrending Stock Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why BioAtla Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How BioAtla Inc. stock performs during market volatilityPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

BioAtla (NASDAQ:BCAB) Stock Price Up 2.6% – Here’s Why - Defense World

Jul 08, 2025
pulisher
Jul 04, 2025

BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma - Yahoo Finance

Jul 04, 2025
pulisher
Jun 20, 2025

BioAtla Approves 2025 Corporate Bonus Plan - TipRanks

Jun 20, 2025
pulisher
Jun 14, 2025

BioAtla, Inc. (NASDAQ:BCAB) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Purchases 100,204 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

BioAtla, Inc. (NASDAQ:BCAB) Stock Position Lowered by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Cuts Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

BioAtla (NASDAQ:BCAB) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025 - MSN

Jun 06, 2025
pulisher
Jun 03, 2025

Why Did BioAtla Inc (NASDAQ: BCAB) Drop So Much? - Stocksregister

Jun 03, 2025
pulisher
Jun 03, 2025

BioAtla reports promising trial results for cancer drug By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

BioAtla reports promising trial results for cancer drug - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

BioAtla (BCAB) Showcases Promising Data for Ozuriftamab Vedotin in Key Cancer Trial | BCAB Stock News - GuruFocus

Jun 02, 2025

Bioatla Inc (BCAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):